Dementia and Alzheimer Disease

The goal for the companies is to reach greater levels of anti-tau antibodies in a single treatment that what current weekly or bi-weekly infusions can achieve.

Findings from a study lends credence to the role of lipids in the early stages of Alzheimer disease.

Many people with dementia continue to drive years after diagnosis. Findings from a systematic review of motor vehicle collisions and driving impairment related to dementia suggest the time to raise concerns over driving safety should be made earlier than originally thought.

These technologies show promise in predicting dementia years before clinical symptoms develop; diagnosing concussion and other brain injuries; and more.

A new forecast model has revealed that an additional 9 million people will develop AD over the next 40 years.

Findings from a new meta-analysis suggest these medications may be most effective in improving cognition in Alzheimer disease.

Bill Gates has taken on an ambitious new project-fighting Alzheimer disease.

Tools to help users monitor and detect tinnitus, control post-stroke symptoms, improve seizure monitoring, and more.

These medical apps provided technology for caregivers to track symptoms, make appointments with doctors, monitor medications, and more.

Higher fish intake was linked to significantly decreased rate of episodic memory decline. More details in this study.

What does epigenetics have to do with risk for Alzheimer disease? Are our epigenetics immutable? What are the therapeutic implications? Those questions answered in this podcast.

A new study is the first to assess the relationship between lithium in drinking water and incidence of dementia.

What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?

In this video, Dr. Lazzara discusses a new study that identified patients at greatest risk of memory loss and global loss of cognitive function.

Which vitamins and supplements have shown promise in treating dementia and preventing cognitive decline?

Creutzfeldt-Jacob disease should be considered in the setting of a rapidly progressive dementia with psychiatric symptoms, ataxia, mutism, myoclonus, and pyramidal or extrapyramidal signs. 

If your patient manifests signs that are compatible with Alzheimer disease, should you recommend olive oil as part of a prevention and treatment regimen? This and other questions answered by Domenico Pratico, MD.

How common is psychosis in PD? Implications? Risk factors? Insights here, and measures that may help.

Researchers are using computer adaptive testing to explore and identify aspects of cognitive performance in a series of computerized neuropsychological tests that best correlate with neurocognitive disease states.

Alzheimer disease is not an equal opportunity employer. Insights about early life stressors and economic disadvantage.

These apps are designed to improve treatment adherence, language skills, symptom tracking, communication, and other helpful functions.

A dementia expert addresses current controversies on proton pump inhibitors.

Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.

These mobile apps provide tools to record medication details and reminders, first aid instructions, step-by-step recovery guides, and other topics of concern for you and your patient.